SUTUREGARD Medical

SUTUREGARD Medical is a private, commercial-stage medical device company offering a novel approach to wound closure. Its core technology, the Adhesive Suture Retention Device (ASRD), is a sterile, single-use adhesive device that mechanically offloads tension from sutured incisions, aiming to reduce wound dehiscence by 80% compared to standard closure according to company-cited studies. The company targets high-tension surgical procedures in orthopedic, vascular, plastic, and general surgery, with a clear reimbursement pathway and early commercial traction evidenced by surgeon testimonials and participation in the MedTech Innovator accelerator. SUTUREGARD operates as a typical medical device company, generating revenue through product sales to hospitals and surgical centers.

Adhesive-based external tension-offloading devices for surgical incisions. The platform utilizes sterile, single-use adhesive strips that distribute mechanical forces away from the suture line to reduce tension, increase perfusion, and prevent wound dehiscence.

SUTUREGARD competes with traditional wound closure methods (sutures, staples, skin adhesives) and advanced preventive measures like negative pressure wound therapy. It occupies a niche focused on mechanical offloading. Potential competitors include large wound care and surgical device companies (e.g., 3M, Ethicon [J&J], Medtronic, Smith & Nephew) that could develop similar adhesive tension-offloading products.